[DOI] [PMC free article] [PubMed] [Google Scholar] 94.Seppa K., Toots M., Reimets R., Jagomae T., Koppel T., Pallase M., Hasselholt S., Krogsbaek Mikkelsen M., Randel Nyengaard J., Vasar E., et al
Your eye care provider may recommend exams every 6 to 12 months depending on your individual risk factors
GLP-1 receptor agonists products approved in the UK for the treatment of Type 2 diabetes mellitus (T2DM) include one oral form (once daily semaglutide tablet marketed as Rybelsus) and seven injection dosage forms self-administered by subcutaneous (SC) injection (twice daily exenatide marketed as Byetta, once daily liraglutide marketed as Victoza, once daily lixisenatide marketed as Lyxumia, once weekly exenatide marketed as Bydureon, once weekly dulaglutide marketed as Trulicity, once weekly semaglutide marketed as Ozempic, once weekly Tirzepatide marketed as Mounjaro)
Unprocessed red and processed meats and risk of coronary artery disease and type 2 diabetes an updated review of the evidence
Hot flushes are not listed as a recognised side effect in official UK prescribing information, though some patients report experiencing them
